SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.
Clinical trial NCT03558191 · COMPLETED
Trial details
- NCT number
- NCT03558191
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-14
- Primary completion
- 2021-12-30
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.